Back
Open Access

HDL as potential therapeutic target.

Session: Biology of high-density lipoproteins: an update
Topic: Atherosclerosis, thrombosis and vascular biology
Speaker: Professor T. Luescher (London, GB)
Event: Frontiers in CardioVascular Biology 2016

Congress Presentation

Add to my library

Like

About the speaker

Professor Thomas Felix Luescher

Royal Brompton Hospital Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
52 presentations
6 followers

4 more presentations in this session

HDL and cardiovascular protection: mechanistic insights.

Speaker: Professor A. Kontush (Paris, FR)

Access
Slides
Like
Thumbnail

Modulation of immune cell function by HDL.

Speaker: Professor G. Norata (Milan, IT)

Access
Like
Thumbnail

High density lipoproteins exert pro-inflammatory effects on macrophages via passive cholesterol depletion and PKC-NF-kB/STAT1-IRF1 signaling

Speaker: Doctor E. van der Vorst (Aachen, DE)

Access
Abstract
Like
Thumbnail

Protein components of HDL as markers of cardiovascular damage in patients with arterial hypertension

Speaker: Mrs M. Mostovyak (Kiev, UA)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Biology of high-density lipoproteins: an update

Speakers: Professor T. Luescher, Professor A. Kontush, Professor G. Norata, Doctor E. van der Vorst, Mrs M. Mostovyak
Access
Like
Thumbnail

About the event

Image

Frontiers in CardioVascular Biology 2016

8 July - 10 July 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources